ECP 2022 Final Programme

Wednesday, 7 Sept Scientific Programme a Wednesday 65 ECP 2022 Basel SY-17 Symposium 08:30–12:00 Montreal ESP Trainees Subcommittee: The future generation of pathologists: challenges and opportunities in pathology research and academia Chairs: Alexandra Vilaia, Romania Daniel Gomes Pinto, Portugal 001 08:30–08:50 Academia–is it worth taking the less travelled road? Martina Bosic, Serbia 002 08:50–09:10 Working in multidisciplinary teams: surviving the tornado of different expert fields Rui Caetano Oliveira, Portugal 003 09:10–09:30 Q&A–Part I 004 10:30–10:50 Translation pathology: a bridge from molecules to patients Ivan Fernandez Vega, Spain 005 10:50–11:10 Tips and tricks to transform your ideas into articles: the journey through the publication process Irene Gullo, Portugal 006 11:10–11:30 Navigating the minefield of applications and interviews Christos Poulios, Belgium 007 11:30–12:00 Q&A–Part II LC-06 Long Course 08:30–12:00 Boston Neuropathology: The 5th edition of the WHO classification of CNS tumours: marching on into the molecular era Chairs: Pieter Wesseling, The Netherlands Pascale Varlet, France 001 08:30–08:50 Introduction to the 5th edition of the WHO Classification of CNS tumours (WHO CNS5) Pieter Wesseling, The Netherlands 002 08:50–09:30 WHO CNS5 diagnosis of gliomas in adults Guido Reifenberger, Germany 003 10:30–11:00 WHO CNS5 diagnosis of paediatric gliomas Pascale Varlet, France 004 11:00–11:30 WHO CNS5 diagnosis of embryonal tumours Christine Haberler, Austria 005 11:30–12:00 ‘Histomolecular’ diagnosis of meningiomas; beyond WHO CNS5 Felix Sahm, Germany SPEC-11 Special Session 08:30–12:00 Delhi Joint Special Session ESP & IARC: Multidisciplinary classification of tumours Chairs: Ian Cree, France Holger Moch, Switzerland 001 08:30–09:00 General principles of tumour classification Ian Cree, France 002 09:00–09:30 Molecular classification of clear cell renal cancer Holger Moch, Switzerland 003 10:30–11:00 Morphology and molecular-based classification of renal tumours Holger Moch, Switzerland 004 11:00–11:30 Tumour classification by mass spectrometry Bernd Bodenmiller, Switzerland 005 11:30–12:00 Challenges of integrating molecular, histological and clinical needs within the CNS classification Guido Reifenberger, Germany